198
Views
16
CrossRef citations to date
0
Altmetric
Research Article

High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group

, , , , , , , , , & show all
Pages 2817-2821 | Received 04 Nov 2013, Accepted 06 Feb 2014, Published online: 24 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Damla Buket Egeli, Benjamin Hanfstein, Michael Lauseker, Markus Pfirrmann, Susanne Saussele, Gabriela M. Baerlocher & Martin C. Müller. (2022) SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment. Leukemia & Lymphoma 63:4, pages 955-962.
Read now
Rong Zhang & Cai-hong Huo. (2020) Long Noncoding RNA SOCS2-AS Promotes Leukemogenesis in FLT3-ITD+ Acute Myeloid Leukemia Through miRNA-221. OncoTargets and Therapy 13, pages 2925-2934.
Read now

Articles from other publishers (14)

Stefan J. Erkeland. (2023) Computational analysis of a microRNA signature for poor prognosis suggests a microRNA ‐controlled stemness pathway in paediatric acute leukaemia . British Journal of Haematology 202:1, pages 11-12.
Crossref
Xi Jin, Victor Ng, Meiling Zhao, Lu Liu, Tomoyasu Higashimoto, Zheng Hong Lee, Jooho Chung, Victor Chen, Gina Ney, Malathi Kandarpa, Moshe Talpaz & Qing Li. (2022) Epigenetic downregulation of Socs2 contributes to mutant N-Ras-mediated hematopoietic dysregulation. Disease Models & Mechanisms 15:5.
Crossref
Mohamed Luban Sobah, Clifford Liongue & Alister C. Ward. (2021) SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer. Frontiers in Medicine 8.
Crossref
Esra’a Keewan & Ksenia Matlawska-Wasowska. (2021) The Emerging Role of Suppressors of Cytokine Signaling (SOCS) in the Development and Progression of Leukemia. Cancers 13:16, pages 4000.
Crossref
Zuyi Yang, Jun Shang, Ning Li, Liang Zhang, Tingting Tang, Guoyan Tian & Xiaohui Chen. (2020) Development and validation of a 10‐gene prognostic signature for acute myeloid leukaemia. Journal of Cellular and Molecular Medicine 24:8, pages 4510-4523.
Crossref
Abdelrahman H. Elsayed, Roya Rafiee, Xueyuan Cao, Susana Raimondi, James R. Downing, Raul Ribeiro, Yiping Fan, Tanja A. Gruber, Sharyn Baker, Jeffery Klco, Jeffrey E. Rubnitz, Stanley Pounds & Jatinder K. Lamba. (2019) A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia. Leukemia 34:3, pages 735-745.
Crossref
Muamera Sarajlic, Theresa Neuper, Kim Tamara Föhrenbach Quiroz, Sara Michelini, Julia Vetter, Susanne Schaller & Jutta Horejs-Hoeck. (2019) IL-1β Induces SOCS2 Expression in Human Dendritic Cells. International Journal of Molecular Sciences 20:23, pages 5931.
Crossref
Lin Fu, Huaping Fu, Qingyun Wu, Yifan Pang, Keman Xu, Lei Zhou, Jianlin Qiao, Xiaoyan Ke, Kailin Xu & Jinlong Shi. (2017) High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions. Journal of Translational Medicine 15:1.
Crossref
Lin Fu, Huaping Fu, Lei Zhou, Keman Xu, Yifan Pang, Kai Hu, Jing Wang, Lei Tian, Yuanyuan Liu, Jijun Wang, Hongmei Jing, Wenrong Huang, Xiaoyan Ke & Jinlong Shi. (2016) High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia. Scientific Reports 6:1.
Crossref
Lin Fu, Huaping Fu, Lei Tian, Keman Xu, Kai Hu, Jing Wang, Jijun Wang, Hongmei Jing, Jinlong Shi & Xiaoyan Ke. (2016) High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia . Oncotarget 7:13, pages 15828-15839.
Crossref
Jin-long Shi, Lin Fu, Qing Ang, Guo-jing Wang, Jun Zhu & Wei-dong Wang. (2015) Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia . Oncotarget 7:3, pages 2585-2595.
Crossref
George S. Laszlo, Todd A. Alonzo, Chelsea J. Gudgeon, Kimberly H. Harrington, Alex Kentsis, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis, Soheil Meshinchi & Roland B. Walter. (2015) High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group. Journal of Hematology & Oncology 8:1.
Crossref
Aaron D. Viny, Christopher J. Ott, Barbara Spitzer, Martin Rivas, Cem Meydan, Efthymia Papalexi, Dana Yelin, Kaitlyn Shank, Jaime Reyes, April Chiu, Yevgeniy Romin, Vitaly Boyko, Swapna Thota, Jaroslaw P. Maciejewski, Ari Melnick, James E. Bradner & Ross L. Levine. (2015) Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis. Journal of Experimental Medicine 212:11, pages 1819-1832.
Crossref
George S. Laszlo, Todd A. Alonzo, Chelsea J. Gudgeon, Kimberly H. Harrington, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis, Soheil Meshinchi & Roland B. Walter. (2015) Multimerin-1 ( MMRN1 ) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group . Clinical Cancer Research 21:14, pages 3187-3195.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.